← Browse by Condition
Medical Condition

anatomic stage iv breast cancer ajcc v8

Total Trials
4
Recruiting Now
4
Trial Phases
Phase 1, Phase 2, Phase 1, Phase 2
NCT04704661 Phase 1
Recruiting

Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial

Enrollment
51 pts
Location
United States
Sponsor
National Cancer Institute (NCI...
View Trial →
NCT04550494 Phase 2
Recruiting

Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations

Enrollment
36 pts
Location
United States
Sponsor
National Cancer Institute (NCI...
View Trial →
NCT03723928
Recruiting

S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer

Enrollment
739 pts
Location
United States, Guam,...
Sponsor
SWOG Cancer Research Network
View Trial →
NCT06026657 Phase 1, Phase 2
Recruiting

Gemcitabine and Ex Vivo Expanded Allogenic Universal Donor, TGFβi Natural Killer (NK) Cells With or Without Naxitamab (Danyelza) for the Treatment of Patients With Metastatic, GD2 Expressing, HER2 Negative Breast Cancer

Enrollment
42 pts
Location
United States
Sponsor
Margaret Gatti-Mays
View Trial →